Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Halozyme Therapeutics $1.5B Debt Financing with The Bank of New York Mellon Trust Company, N.A.
Halozyme Therapeutics completed the sale of $1.5 billion in 1.50% Convertible Senior Notes due 2033, which included a $200 million overallotment option exercised by initial purchasers. The company used the proceeds to fund capped call transactions and to repurchase approximately $652.5 million of its existing 0.25% notes due 2027 and 1.00% notes due 2028.
Rocket One M&A Deal with Tracer Drone Technologies, LLC
Rocket One Inc. has entered into a definitive agreement to acquire 100% of Tracer Drone Technologies, LLC, a provider of drone hardware, software, and managed services. The acquisition aims to accelerate Rocket One's expansion into AI-enabled autonomous and counter-UAS technologies for public safety and defense markets. Tracer will operate as a wholly owned subsidiary upon the closing of the transaction.
Apollo Debt Solutions BDC Announces $700M Stock Buyback
Apollo Debt Solutions BDC (ADS) provided an update on its Q3 2026 share repurchase program, stating it will honor repurchase requests for 5% of shares outstanding, totaling approximately $700 million. The Fund received total repurchase requests for 14.7% of shares outstanding but is limiting outflows to its designated 5% quarterly liquidity cap. ADS reported $4.8 billion in available liquidity and a year-to-date net total return of 3.7% for Class I shares.
Interparfums has entered into an exclusive, worldwide license agreement with PUMA for the creation, development, production, and distribution of fragrances under the PUMA brand. The agreement runs through December 31, 2037, with the company planning to launch a new signature lifestyle fragrance in 2027.
Ares Commercial Real Estate Divestiture to unaffiliated buyer for $64M
Ares Commercial Real Estate Corporation completed the sale of a multi-building office property in North Carolina for $64 million in cash. The company had previously acquired the property through a deed in lieu of foreclosure in September 2024 and had classified it as held for sale since early 2026.
Apollo Debt Solutions BDC declared monthly distributions for September 2026 of $0.1800 per share for Class I, S, and D common shares. The company also reported a net asset value (NAV) per share of $23.84 as of August 31, 2026, and disclosed the sale of approximately $8.5 million in Class I common shares through a private offering.
Energy Vault Holdings $25M Debt Financing with S2G Builders Special Opportunities Fund I, LP
Energy Vault's subsidiary, Development Vault, LLC, entered into an amended and restated financing agreement for a $25 million senior secured delayed draw term loan facility. The facility, which currently has $18 million outstanding, carries a 10.0% cash interest rate plus a 7.0% PIK interest rate and matures in April 2030. Proceeds will be used to fund the acquisition and development of battery energy storage projects, including equipment deposits and interconnection costs.
Alaunos Therapeutics entered into a securities purchase agreement for a registered direct offering of 380,469 shares of common stock and 386,654 pre-funded warrants. The offering was priced at $1.46 per share, generating aggregate gross proceeds of approximately $1.12 million. The company intends to use the net proceeds for general corporate purposes and working capital.
Caring Brands, Inc. appointed Brian R. Meadows as Chief Financial Officer and principal financial officer, effective September 18, 2026, succeeding Brian John who resigned as Interim CFO and Chairman. Dr. Glynn Wilson, the current CEO, was appointed as the new Chairman of the Board. Mr. Meadows will provide services through a consulting agreement with Myall Luna Ventures Inc., which was amended to increase the monthly fee from $10,000 to $15,000.
Mr. Amihay Hadad has stepped down as Co-Chief Executive Officer of Quantum X Labs Inc., effective September 22, 2026. Consequently, Mr. Yakov Baranes, who previously served as Co-CEO, has been appointed as the company's sole Chief Executive Officer.
Black Hawk Acquisition Corporation has deposited $150,000 into its trust account to extend the deadline for completing its initial business combination. The extension moves the deadline by one month, from September 22, 2026, to October 22, 2026.
First Eagle Private Credit Fund declared regular September 2026 distributions of $0.210 per share for both Class I and Class D common shares. The distributions are payable on October 29, 2026, to shareholders of record as of September 30, 2026. The filing also updated the Fund's NAV to $23.74 per share as of August 31, 2026.
Ares Strategic Income Fund declared monthly distributions for September, October, November, and December 2026 for its Class I, S, and D shares. The gross distribution for each month is set at $0.21430 per share, with the September distribution payable on October 23, 2026, to shareholders of record as of September 30, 2026.
Group 1 Automotive $1.25B Debt Financing with Computershare Trust Company, N.A.
Group 1 Automotive completed a private offering of $1.25 billion in senior notes, consisting of $625 million of 6.250% notes due 2032 and $625 million of 6.625% notes due 2035. The company intends to use the net proceeds of approximately $1,236 million to fund its previously announced acquisition of dealership assets from Hennessy Automobile Companies, Inc. and to repay existing credit facility debt.
Medallion Bank, a subsidiary of Medallion Financial Corp., has launched a public offering of additional shares of its Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series G. The bank intends to use the proceeds for general corporate purposes, which may include redeeming its outstanding Series E Preferred Stock.
Vistagen announced preliminary positive data from the open-label extension portion of its PALISADE-4 Phase 3 study of fasedienol for social anxiety disorder. The data showed the nasal spray was well-tolerated over 12 months of as-needed use and demonstrated clinically relevant improvements in social anxiety symptoms on both clinician-administered and patient-reported scales. The company plans to meet with the FDA this quarter to discuss the regulatory path forward for a potential New Drug Application.
The Bank of New York Mellon Corporation filed a Certificate of Elimination to its Restated Certificate of Incorporation to remove all designations related to its Series F Noncumulative Perpetual Preferred Stock. This administrative action follows the full redemption of all outstanding Series F shares on September 20, 2026.
Worthington Enterprises reported fiscal 2027 first quarter results with net sales increasing 13% to $343.9 million and net earnings rising 22% to $42.6 million. The company achieved 7% organic growth and nearly doubled its free cash flow to $54.0 million while also declaring a $0.20 per share quarterly dividend.
Term
Q1 2027
Earnings call
Sep 23, 2026, 8:30 AM ET
“We started fiscal 2027 with solid performance as our teams continued to execute well and deliver for our customers. We generated 7% organic growth, grew adjusted EBITDA by 10% and nearly doubled free cash flow. These results reflect the progress we are making as we continue to optimize and grow Worthington Enterprises.”
LeonaBio announced that Series A Common Warrants issued in a December 2025 private placement have become exercisable as of September 18, 2026. If the warrants are exercised in full for cash at the $6.35 exercise price, the company would receive approximately $146.2 million in additional capital. The warrants remain exercisable until October 19, 2026.
Aldel Financial II Inc. announced that its sponsor and other holders will convert 6,160,713 Class B ordinary shares into Class A ordinary shares on a one-for-one basis effective October 5, 2026. Following the conversion, the company will have 29,868,213 Class A shares and only one Class B share outstanding. The holders waived any rights to funds in the company's trust account regarding these converted shares.
Reborn Coffee received a deficiency notice from Nasdaq on September 16, 2026, for failing to meet the minimum stockholders' equity requirement of $2.5 million, reporting only $735,642 in its latest quarterly filing. The company has until November 2, 2026, to submit a plan to regain compliance, which could lead to a 180-day extension if accepted. Separately, Nasdaq confirmed the company regained compliance regarding its periodic filing requirements after the late 10-Q was submitted.
CoreWeave $4.2B Debt Financing with U.S. Bank Trust Company, National Association
CoreWeave completed an upsized private offering of $4.2 billion in 2.875% Convertible Senior Notes due 2033, which included the full exercise of a $500 million overallotment option. The notes are senior unsecured obligations guaranteed by certain subsidiaries and are convertible into cash, Class A common stock, or a combination thereof at an initial conversion price of approximately $97.85 per share.
KB Home reported Q3 2026 revenues of $1.30 billion, a 20% year-over-year decrease, and diluted EPS of $1.05. The company noted a challenging housing market due to higher mortgage rates but achieved its goal of returning to a predominantly Built to Order business model. During the quarter, the company also repurchased $50.0 million of its common stock.
Term
Q3 2026
Earnings call
Sep 22, 2026, 5:00 PM ET
“We are operating in a housing market that continues to be challenging, with conditions weakening since our June earnings report. Higher mortgage interest rates have further pressured affordability and, together with geopolitical uncertainty and broader economic headwinds, have caused many prospective buyers to be more cautious on purchasing a home.”
Jeffrey Mezger, Executive Chairman
“We also made significant progress and have now achieved our goal of returning to a predominantly Built to Order business, with BTO homes representing nearly three-quarters of our deliveries in the third quarter, which contributed to our sequentially higher housing gross profit margin.”
Robert McGibney, President and Chief Executive Officer
Quoin Pharmaceuticals announced that the FDA has granted Fast Track Designation to its lead asset, QRX003, for the treatment of Peeling Skin Syndrome. This is the first-ever Fast Track Designation granted for this rare genetic skin disease, which currently has no approved treatments. The company expects to initiate a Phase 2/3 clinical study for the indication in the second half of 2026.
Palmer Square Capital BDC Inc. declared a third quarter 2026 supplemental dividend of $0.02 per share. This is in addition to the previously declared base dividend of $0.36 per share, with both scheduled for payment on October 13, 2026, to shareholders of record as of September 25, 2026.
Associated Banc-Corp entered into an employment transition agreement with Randall J. Erickson, who will retire as General Counsel on October 13, 2026. Erickson will serve as an Attorney-Advisor through January 4, 2027, maintaining his current base salary and eligibility for his full 2026 short-term incentive and continued vesting of long-term incentive awards. This agreement formalizes the compensation and transition terms for his departure and advisory period.
Take-Two Interactive Software held its 2026 Annual Meeting of Stockholders where shareholders elected ten directors, approved executive compensation on an advisory basis, and ratified Ernst & Young LLP as auditors. Additionally, stockholders approved a charter amendment to limit the liability of certain officers as permitted by Delaware law.
TriSalus Life Sciences received FDA 510(k) clearance for its TriNav Advance device, an expansion of its Pressure-Enabled Drug Delivery (PEDD) portfolio. The device is designed to access small, distal vessels during liver embolization procedures and the company expects to commence commercialization in the coming weeks.
ProPetro Holding Wins Contract from Targa Resources Corp.
ProPetro's PROPWR business unit entered into long-term contracts to commit approximately 230 megawatts of power generation capacity to a subsidiary of Targa Resources Corp. The behind-the-meter power will support Targa's natural gas processing infrastructure in the Permian Basin, with full deployment expected in early 2028.
Federal Home Loan Bank of Des Moines $2.64B Debt Financing with Office of Finance
The Federal Home Loan Bank of Des Moines committed to issue approximately $2.64 billion in consolidated obligation bonds and notes between September 16 and September 18, 2026. These debt securities include both fixed-rate and variable-rate instruments with maturities ranging from 2027 to 2036. The obligations are joint and several liabilities of the eleven Federal Home Loan Banks used to fund operations and provide liquidity to members.